NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Specialty Chemicals · USD

Balchem Corporation (BCPC) Stock Analysis

Balchem Corporation (BCPC) is a Specialty Chemicals stock listed on NASDAQ and quoted in US Dollar.

BCPC

$171.61

−$0.13 (−0.08%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare BCPC with… →

BCPC Key Statistics

As of Sep 4, 2026
Trading
Open
$170.03
Previous Close
$171.74
Day's Range
170.00–172.53
52-Week Range
139.17–183.90
Volume
89.90K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.81
Valuation
Market Cap
$5.47B
P/E Ratio
33.78
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
27.36
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
3.32
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
5.04
EPS (ttm)Profit attributable to each share over the last twelve months.
5.08
Financials (FY)
Revenue (FY)
$1.04B+8.75%
Net Income (FY)
$154.85M+20.53%
Profit marginThe share of revenue left as profit after all costs and taxes.
15.14%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
31.88M
1-Year Return
+6.98%
Dividend and dates
Dividend
$0.96+0.56%
Ex-Dividend Date
December 23, 2025
Earnings Date
October 20, 2026
Avg Volume
214.33K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

BCPC Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+11.90%
2025−5.34%
2024+10.15%
2023+22.48%
2022−27.15%
2021+46.90%
2020+13.96%
2019+30.38%
2018−2.19%
2017−3.46%
2016 (partial year)+29.15%

As of September 4, 2026.

BCPC Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$1.04B$154.85M14.9%
2024$953.68M$128.48M13.5%
2023$922.44M$108.54M11.8%
2022$942.36M$105.37M11.2%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$1.04B$370.63M$209.33M$154.85M14.9%
2024$953.68M$336.21M$182.91M$128.48M13.5%
2023$922.44M$302.06M$159.19M$108.54M11.8%
2022$942.36M$280.45M$145.19M$105.37M11.2%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

BCPC Dividend History

$0.96+10.3% vs 2024

Dividends per share, 2025 · 1 payments

YearDividends per sharePaymentsChange
2025$0.961+10.3%
2024$0.871+10.1%
2023$0.791+11.3%
2022$0.711+10.9%
YearDividends per sharePaymentsChange
2025$0.961+10.3%
2024$0.871+10.1%
2023$0.791+11.3%
2022$0.711+10.9%
2021$0.641+10.3%
2020$0.581+11.5%
2019$0.521+10.6%
2018$0.471+11.9%
2017$0.421+10.5%
2016$0.381—

Most recent payment: $0.96 per share, ex-dividend December 23, 2025. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

BCPC Valuation vs Specialty Chemicals Median

Median of 71 stocks
MetricBCPCSpecialty Chemicals medianvs median
P/E33.7828.7118% above
P/S ratio5.041.683.0x the median
Profit margin15.14%0.08%15.1 pts above

Medians across 71 Specialty Chemicals stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Balchem Corporation (BCPC) carries a market capitalisation of $5.47B. It is classified in the Specialty Chemicals industry, within the Basic Materials sector. The company reports 1,379 employees.

BCPC last closed at $171.61 on September 4, 2026. That is −$0.13 (−0.08%) against the previous close. The 52-week range on file runs from $139.17 to $183.90. The latest close sits 23.31% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $1.04B. That is +8.75% against the prior fiscal year, when revenue was $953.68M. The same year closed with net income of $154.85M. That is +20.53% against the prior fiscal year. Profit margin runs at 15.14%. That is 15.1 percentage points above the Specialty Chemicals median of 0.08%. Trailing earnings per share are 5.08.

Across the 4 fiscal years on file, revenue moves from $942.36M in 2022 to $1.04B in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

On trailing earnings, the shares are priced at 33.78 times earnings. That is 17.66% above the Specialty Chemicals median of 28.71. The forward P/E on file is 27.36. The PEG ratio, which sets the P/E against expected earnings growth, reads 3.32. The price-to-sales ratio is 5.04. On price-to-sales that is 3 times the Specialty Chemicals median of 1.68. 71 Specialty Chemicals companies report these metrics, and the medians quoted come from that group.

The trailing one-year price return is +6.98%. Measured over 10 years, that is +9.96% a year compounded. The reported beta is 0.81. Annualized volatility over the trailing 10 years is 26.78%.

Growth & Income

The trailing dividend yield is 0.56%. That is 1.3 percentage points below the Specialty Chemicals median yield of 1.83%. At the indicated rate that is $0.96 a share a year. The ex-dividend date on file is December 23, 2025. Dividends are recorded for 10 calendar years; 2025 shows 1 payments totalling $0.96 a share. The year before, 2024, totalled $0.87 a share.

Across the complete calendar years on file, 2021 returned +46.90% and 2022 returned −27.15%. Of the 9 complete calendar years on file, 5 finished higher. 2026 is still running; the price is +11.90% year to date.

Peer Comparison

Balchem Corporation (BCPC) operates in the Specialty Chemicals industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Balchem Corporation BCPC $5.47B 33.8
Linde plc LIN $220.15B 30.9
The Sherwin-Williams Company SHW $81.01B 30.8
Ecolab Inc. ECL $78.29B 37.4

The Specialty Chemicals industry average P/E ratio is 28.7x. Balchem Corporation trades at a P/E of 33.8.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Specialty Chemicals Stocks

LIN

Linde plc

$220.15B

 SHW

The Sherwin-Williams Company

$81.01B

 ECL

Ecolab Inc.

$78.29B

 APD

Air Products and Chemicals, Inc.

$67.09B

 PPG

PPG Industries, Inc.

$25.02B

 IFF

International Flavors & Fragrances Inc.

$22.03B
View all Specialty Chemicals stocks →

Popular Basic Materials Stocks

BHP

BHP Group Limited

$229.80B

 RIO

Rio Tinto Group

$167.95B

 SCCO

Southern Copper Corporation

$167.82B

 NEM

Newmont Corporation

$134.97B

 FCX

Freeport-McMoRan Inc.

$104.44B
View all Basic Materials stocks →

About Balchem Corporation

Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.

Visit website →